Back

Nicotinamide-N-methyltransferase inhibition improves cardiac function and structure in a heart failure with preserved ejection fraction mouse model

17 May 2025 (12:00 - 13:00)
Organised by: Logo
Congress Presentation Part of: ePosters in chronic heart failure - pathophysiology and mechanisms (2) Experimental Heart Failure HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Mr Sunhuo Li

University Medical Centre Groningen, Groningen (Netherlands (The))

7 More presentations in this session

Presentation thumbnail
Multimodal predictive model for 6-month treatment-related cardiotoxicity in non-Hodgkin lymphoma patients
Doctor D. Bursacovschi (Chisinau, MD)
Abstract Slides Video
Presentation thumbnail
Deciphering doxorubicin-induced cardiotoxicity:insights at single-cell resolution
Mr J. Van Fraeyenhove (Turin, IT)
Abstract Slides Video
Presentation thumbnail
Takotsubo syndrome stress induced heart failure syndrome with significant LVOT obstruction
Doctor D. Kutlesic Kurtovic (Nis, RS)
Abstract Slides Video
Presentation thumbnail
Evaluation of the predictive value of the HFA-ICOS score for cardiotoxicity in breast cancer patients treated with anthracyclines and trastuzumab: a real-world observational study
Doctor D. Faro (Catania, IT)
Abstract Slides Video
Presentation thumbnail
Evaluating systemic vascular resistance in response to stress facilitates identification of heart failure
Professor D. Jakovljevic (Newcastle-Upon-Tyne, GB)
Abstract Slides Video

Access the full session

Session thumbnail
ePosters in chronic heart failure - pathophysiology and mechanisms (2)

The Event

Event poster

Heart Failure 2025

17 May 2025 12:00 CET
You may be interested in
thumbnail
Congress Presentation
ACEI plus GLP1-RA or SGLT2i, as well as ARNI, exerted distinct protective effects against diabetic nephropathy and heart failure with preserved ejection fraction in eNOS-/- dbdb mice.
thumbnail
Congress Presentation
Treatment of diastolic dysfunction by targeting beta-adrenergic receptors in vivo in a murine model of cardiometabolic HFpEF
thumbnail
Congress Presentation
Effects of sacubitril-valsartan alone or in combination with dapagliflozin on aging-related heart failure with preserved ejection fraction

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources